Shandong Kexing Bioproducts Co., Ltd.

Kexing Biopharm is an innovative biopharmaceutical enterprise mainly engaged in the R&D, production and sales of recombinant protein therapeutics and microecological agents. We focus on pharmaceutical research in the therapeutic fields of antiviral, oncology, immunology, hematology, digestion and degenerative diseases.

At present, our main products include the recombinant protein therapeutics " Human Erythropoietin (EPOSINO)", " Human Interferon α 1b (SINOGEN)" and " Human Granulocyte Colony-stimulating Factor (WHITE-C)", as well as the microecological agent "Combined Clostridium Butyricum and Bifidobacterium (CLOBICO)".

In recent years, we have achieved continued and rapid growth in its business, becoming a leader in the recombinant protein therapeutics industry. Our core products, remained at the forefront of similar varieties in China, have been adopted by over 18, 000 sales terminals, including over 6500 hospitals in the provinces, municipalities and regions across China, and accessed into and sold in over 30 countries, including Brazil, Philippines and Indonesia.

With over two decades of accumulation in pharmaceutical R&D and industrialization, we have established a complete system of pharmaceutical R&D innovation, covering pharmaceutical innovation capabilities from pharmaceutical discovery, pharmaceutical research, preclinical research and clinical research to industrialized production. Depending on prokaryotic cell technology, eukaryotic cell technology and viable bacteria technology, we have built 5 world-leading technology platforms, including strain platform, recombinant protein therapeutics industrialization platform, microecological agent R&D and industrialization platform, recombinant protein secretion and expression platform and long-acting recombinant protein platform. At present, we have obtained 39 patents, with 9 biopharmaceutical projects under research, including 3 projects of new biopharmaceuticals.

Following the mission of "Precise Products, Predictable Effects, Health Protection", we are devoted to providing patients with biotechnology, becoming the leader of high quality biologicals.